Amplification of HER2 is not involved in resistance to docetaxel in breast cancer cell lines.

Sarah McDonald, David A J Stevenson, Steven Darryll Heys, Andrew Craig Schofield

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)820-821
Number of pages1
JournalEuropean Journal of Surgical Oncology
Volume29
Publication statusPublished - 2003

Cite this

McDonald, S., Stevenson, D. A. J., Heys, S. D., & Schofield, A. C. (2003). Amplification of HER2 is not involved in resistance to docetaxel in breast cancer cell lines. European Journal of Surgical Oncology, 29, 820-821.